BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27689405)

  • 1. Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer.
    Del Mar Valenzuela-Membrives M; Perea-García F; Sanchez-Palencia A; Ruiz-Cabello F; Gómez-Morales M; Miranda-León MT; Galindo-Angel I; Fárez-Vidal ME
    Oncotarget; 2016 Nov; 7(44):71608-71619. PubMed ID: 27689405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients.
    Prado-Garcia H; Aguilar-Cazares D; Flores-Vergara H; Mandoki JJ; Lopez-Gonzalez JS
    Lung Cancer; 2005 Mar; 47(3):361-71. PubMed ID: 15713519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic parameters as significant prognostic factors in lung cancer.
    Nakamura H; Saji H; Ogata A; Hosaka M; Hagiwara M; Kawasaki N; Konaka C; Kato H
    Lung Cancer; 2002 Aug; 37(2):161-9. PubMed ID: 12140139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PD1 and BTLA on the CD8
    Bao Y; Mo JF; Wu JY; Cao CX
    Chin Med Sci J; 2019 Nov; 34(4):248-255. PubMed ID: 33906710
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease.
    Mazzoccoli G; Balzanelli M; Giuliani A; De Cata A; La Viola M; Carella AM; Bianco G; Tarquini R
    In Vivo; 1999; 13(3):205-9. PubMed ID: 10459492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
    Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
    Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
    Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
    Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
    Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes and clinical significance of innate-like lymphocyte subsets in peripheral blood of patients with advanced non-small cell lung cancer].
    Wei T; Han X; Xia X; Ma F; Yao C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):671-5. PubMed ID: 27126948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).
    Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D
    Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
    Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer.
    Trojan A; Urosevic M; Dummer R; Giger R; Weder W; Stahel RA
    Lung Cancer; 2004 May; 44(2):143-7. PubMed ID: 15084378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
    Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
    Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.